Edgewise Therapeutics Inc (EWTX)
28.40
+1.77
(+6.65%)
USD |
NASDAQ |
Oct 04, 16:00
28.00
-0.40
(-1.41%)
After-Hours: 20:00
Edgewise Therapeutics Shareholders Equity (Annual): 318.83M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 318.83M |
| December 31, 2022 | 346.72M |
| December 31, 2021 | 274.38M |
| Date | Value |
|---|---|
| December 31, 2020 | -33.42M |
| December 31, 2019 | -16.85M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-33.42M
Minimum
2020
346.72M
Maximum
2022
177.93M
Average
274.38M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Catalyst Pharmaceuticals Inc | 387.88M |
| Vertex Pharmaceuticals Inc | 17.58B |
| Sarepta Therapeutics Inc | 859.34M |
| Regenxbio Inc | 311.74M |
| Entrada Therapeutics Inc | 242.36M |